Moderate

Chronic spontaneous urticaria (chronic idiopathic urticaria)

chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, chronic urticaria, omalizumab, antihistamine updosing, inducible urticaria · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Recurrent itchy weals and/or angioedema occurring most days for more than 6 weeks without a consistent external trigger (spontaneous), driven by mast-cell activation. Individual weals last <24 h. Often associated with autoimmunity (thyroid). Distinct from acute urticaria and anaphylaxis. Managed by a stepwise ladder of second-generation antihistamines, up-dosing, then omalizumab.

Red flags

  • Angioedema with airway/tongue/throat involvement or any anaphylaxis - treat as emergency (adrenaline)
  • Weals lasting >24 h, painful or leaving bruising/pigmentation - urticarial vasculitis (biopsy, systemic workup)
  • Angioedema WITHOUT weals, poorly responsive to antihistamines - consider ACE-inhibitor or hereditary/acquired C1-inhibitor angioedema (bradykinin pathway)
  • Fever, arthralgia, weight loss, raised inflammatory markers - autoinflammatory/systemic disease (Schnitzler, Still's)
  • Systemic symptoms with flushing - consider mastocytosis

Assessment

Differential diagnosis

  • Acute urticaria / anaphylaxis (airway/CV compromise)
  • Urticarial vasculitis (weals >24 h, painful, bruising, leave pigmentation)
  • Inducible (physical) urticaria - dermographic, cholinergic, cold, delayed pressure
  • Bullous pemphigoid (urticarial prodrome in elderly)
  • Mastocytosis / urticaria pigmentosa
  • Autoinflammatory syndromes (e.g. Schnitzler, CAPS) if fever/systemic
  • Hereditary/ACE-inhibitor angioedema (angioedema WITHOUT weals)

Investigations

  • Clinical diagnosis; confirm individual weals resolve within 24 h and no systemic trigger
  • Limited tests unless features suggest otherwise: FBC, CRP/ESR (consider urticarial vasculitis if raised), thyroid function + thyroid autoantibodies
  • Do NOT do broad allergy testing in spontaneous urticaria - it is not allergic
  • Skin biopsy only if urticarial vasculitis suspected (weals >24 h, painful, purpuric)
  • Assess disease activity/control (e.g. UAS7, UCT) to guide step-up

Management

  • Confirm CSU and exclude mimics (vasculitis, angioedema-without-weals, systemic autoinflammatory disease)
  • Step 1: regular (not prn) second-generation H1-antihistamine at standard licensed dose; avoid sedating first-generation and known aggravators (NSAIDs, opiates, alcohol)
  • Step 2: if uncontrolled after 2-4 weeks, up-dose the same second-generation antihistamine up to 4-fold (off-licence but guideline-recommended)
  • Step 3: if still uncontrolled on 4x dosing, add omalizumab (anti-IgE)
  • Step 4: omalizumab non-responders - ciclosporin (specialist)
  • Treat associated angioedema; provide adrenaline auto-injector only if true anaphylaxis risk (not for isolated CSU)
  • Give a written action plan and review disease control; most cases remit over months-years
  • Short oral corticosteroid courses only for severe exacerbations - avoid long-term steroids

Drugs & doses

Cetirizine 10 mg ORAL once daily (or fexofenadine 180 mg, loratadine 10 mg, bilastine 20 mg, desloratadine 5 mg) - regular dosing
Up-dosed second-generation antihistamine: e.g. cetirizine up to 10 mg four times daily, or fexofenadine 180 mg twice-four times daily (up to 4x standard dose) [verify local]
Omalizumab 300 mg SC every 4 weeks (second-line add-on; some respond to 150 mg) [verify local]
Ciclosporin 2.5-5 mg/kg/day ORAL in 2 divided doses for omalizumab-refractory disease - specialist, monitor BP/renal [verify local dose]
Prednisolone short course (e.g. 20-40 mg ORAL once daily for 3-7 days) for severe flares only - not for maintenance [verify local dose]
Avoid: regular first-generation sedating antihistamines, long-term systemic corticosteroids

Disposition

Outpatient/GP management with the antihistamine ladder and a written plan. Refer to dermatology/immunology/allergy for omalizumab candidates, diagnostic doubt, suspected urticarial vasculitis or systemic disease. Emergency care only for anaphylaxis/airway angioedema.

Complications & pitfalls

  • Significant sleep disturbance and impaired quality of life
  • Angioedema (disfiguring; rarely airway)
  • Adverse effects of long-term/high-dose corticosteroids if misused
  • Anxiety/depression from chronic unpredictable disease
  • Missed urticarial vasculitis or systemic disease

Exam pearls

  • 2024 international (EAACI/GA2LEN/WAO) urticaria guideline ladder: regular 2nd-gen antihistamine -> up-dose up to 4x -> add omalizumab -> ciclosporin
  • CSU is not allergic - extensive allergy testing and elimination diets are unhelpful; reassure
  • Up-dosing antihistamines up to 4-fold is safe and guideline-endorsed before escalating
  • Avoid regular systemic corticosteroids for maintenance (rebound, toxicity) - reserve short courses for flares
  • Weals that are painful, last >24 h or bruise suggest urticarial vasculitis - biopsy
  • Angioedema without weals and antihistamine-unresponsive points to bradykinin-mediated angioedema - different treatment

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.